Tularemia is a zoonotic disease and endemic in the northern hemisphere. The gram-negative coccobacillus Francisella tularensis causes this disease (Ellis et al., 2002). It is a facultative intracellular pathogen that mostly proliferates in host macrophages (Pechous et al., 2009). F. tularensis is endemic also in Turkey, and infection occurs via several routes and results in different clinical syndromes (Gotschlich & Berkin, 2007). In general, laboratory workers, farmers and gardeners are at a higher risk of contacting with tularemia. Clinical symptoms vary from asymptomatic disease to septic shock and death, depending on the infecting strain, site of infection, bacterial load, and the host immune status (Penn, 2010). The most common route of the disease transmission is contact with infected animals and ticks, and that in our country is the intake of contaminated natural or non-chlorinated water (Gürcan et al., 2004; Willke et al., 2009). The diagnosis of tularemia is usually given lately because it is seen with lymphadenopathy; it is confused with nonspecific laboratory findings and nonspecific pathological findings; and it is not considered usually in differential diagnosis. The epidemiology of the cases may change over time and the incidence of the clinical forms of the tularemia may change accordingly. In this study, we aimed to evaluate tularemia cases in this respect and compare them with regional and world literature. The aim of this study was to evaluate the epidemiological, clinical and laboratory characteristics of tularemia patients, and reanalyze their physical conditions and lymphadenopathy during the follow-up. MATERIALS AND METHODS Study design, settings and ethics This study has been conducted in accordance with the principles of the Helsinki Declaration and approved by the local Institutional Review Board (date of the approval: 04/05/ 2017, number of the approval: 08/20). Patients who were diagnosed with tularemia in the National reference laboratory and monitored in our clinic between 2011 and 2017 were retrospectively reviewed. All patients who were diagnosed with tularemia were included in the study. Their age, sex, epidemiologic anamnesis, symptoms, physical condition, complete blood count, creactive protein, erythrocyte sedimentation rate, tularemia polymerase chain reaction, Micro-agglutination titration (MAT), imaging, pathology results, treatment regimens and follow-ups were recorded. In addition, all patients were invited for the second time. The patients were contacted by telephone and invited to our outpatient clinic for the long term, physical, laboratory and radiological evaluations. All patients provided signed consents after they agreed to participate in the study. Patients who could not reach out from their recorded phone numbers